Geriatric Pharmacology Impact Factor|OMICS International|Journal Of Gerontology And Geriatric Research

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Webinars & Conferences

2nd world No diabetes and Obestity

Berlin, Germany

2nd Modern Trends in Dementia and Alzheimers

London, UK

Geriatric Pharmacology Impact Factor

The branch of science that is related to skin, hair and nails is called as geriatric pharmacology it is basically related to the elderly people. Geriatric Pharmacology is related to the medicines that can be provided to the elderly people to cure their diseases. Those are light medicines as that will be given to old age people. Adverse Drug Event (ADE) or Drug-Drug Interaction (DDI) increases proportionately with the number of drugs. Liver activity and Renal function declines in elderly people; it will be about 1% per year over age 50. This is notably increased if the patient is also dehydrated. The majority of drugs are excreted renally and so at risk to accumulate. The impact factor of journal provides quantitative assessment tool for grading, evaluating, sorting and comparing journals of similar kind. It reflects the average number of citations to recent articles published in science and social science journals in a particular year or period, and is frequently used as a proxy for the relative importance of a journal within its field. It is first devised by Eugene Garfield, the founder of the Institute for Scientific Information. The impact factor of a journal is evaluated by dividing the number of current year citations to the source items published in that journal during the previous two years.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on April, 2021